ArticleActa pharmacologica Sinica2025

Co-delivery of shikonin and JQ1 inhibits triple-negative breast tumor progression and lung metastasis through inhibition of epithelial-mesenchymal transition and vasculogenic mimicry.

Xing-Yu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.